BR9406923A - Compostos derivados de (1-heteroazolil-1-heterociclil)alcano processo para preparar os mesmos formulaçao farmaceutica uso de compostos e processo para o tratamento de disturbios neuropsiquiatricos cronicos e agudos - Google Patents
Compostos derivados de (1-heteroazolil-1-heterociclil)alcano processo para preparar os mesmos formulaçao farmaceutica uso de compostos e processo para o tratamento de disturbios neuropsiquiatricos cronicos e agudosInfo
- Publication number
- BR9406923A BR9406923A BR9406923A BR9406923A BR9406923A BR 9406923 A BR9406923 A BR 9406923A BR 9406923 A BR9406923 A BR 9406923A BR 9406923 A BR9406923 A BR 9406923A BR 9406923 A BR9406923 A BR 9406923A
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- heteroazolyl
- heterocyclyl
- chronic
- acute
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE19939302332A SE9302332D0 (sv) | 1993-07-06 | 1993-07-06 | New compounds |
| PCT/SE1994/000663 WO1995001979A1 (en) | 1993-07-06 | 1994-07-05 | Novel (1-heteroazolyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9406923A true BR9406923A (pt) | 1996-07-30 |
Family
ID=20390539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9406923A BR9406923A (pt) | 1993-07-06 | 1994-07-05 | Compostos derivados de (1-heteroazolil-1-heterociclil)alcano processo para preparar os mesmos formulaçao farmaceutica uso de compostos e processo para o tratamento de disturbios neuropsiquiatricos cronicos e agudos |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US5731335A (pt) |
| EP (1) | EP0707584A1 (pt) |
| JP (1) | JPH08512312A (pt) |
| CN (1) | CN1126994A (pt) |
| AU (1) | AU691506B2 (pt) |
| BR (1) | BR9406923A (pt) |
| CA (1) | CA2164856A1 (pt) |
| CZ (1) | CZ5396A3 (pt) |
| EE (1) | EE03193B1 (pt) |
| EG (1) | EG20569A (pt) |
| FI (1) | FI960076A0 (pt) |
| HU (1) | HUT75097A (pt) |
| IL (1) | IL110157A (pt) |
| IS (1) | IS4182A (pt) |
| MX (1) | MX9405110A (pt) |
| NO (1) | NO305955B1 (pt) |
| NZ (1) | NZ268689A (pt) |
| PL (1) | PL176471B1 (pt) |
| RU (1) | RU2124011C1 (pt) |
| SE (1) | SE9302332D0 (pt) |
| SG (1) | SG64891A1 (pt) |
| SK (1) | SK159895A3 (pt) |
| WO (1) | WO1995001979A1 (pt) |
| ZA (1) | ZA944569B (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9604242D0 (en) | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
| DE19645313A1 (de) | 1996-11-04 | 1998-05-07 | Basf Ag | Substituierte 3-Benzylpyrazole |
| EP1047423B1 (en) * | 1997-11-19 | 2006-05-10 | Takeda Pharmaceutical Company Limited | Novel apoptosis inhibitors |
| GB9726569D0 (en) * | 1997-12-16 | 1998-02-11 | Univ Southampton | Neuroprotective agents |
| AR035016A1 (es) | 1999-08-25 | 2004-04-14 | Takeda Chemical Industries Ltd | Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima. |
| NZ520875A (en) * | 2000-03-24 | 2005-04-29 | Euro Celtique S | Aryl substituted pyrazoles, triazoles and tetrazoles as sodium channel blocker |
| EP1709019B1 (en) | 2004-01-12 | 2007-08-08 | Applied Research Systems ARS Holding N.V. | Thiazole derivatives and use thereof |
| EP1794167A4 (en) * | 2004-09-10 | 2009-10-21 | Syngenta Ltd | SUBSTITUTED ISOXAZOLE AS FUNGICIDES |
| US7888376B2 (en) * | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| RU2472788C9 (ru) * | 2007-05-23 | 2013-04-20 | Аллерган, Инк. | (бициклогетероарил)имидазолил)метилгетероарильные соединения как агонисты адренергических рецепторов |
| WO2009123164A1 (ja) * | 2008-04-02 | 2009-10-08 | 塩野義製薬株式会社 | 血管内皮リパーゼ阻害活性を有するヘテロ環誘導体 |
| EP2595985A1 (en) * | 2010-07-19 | 2013-05-29 | Syngenta Participations AG | Isoxazole, isothiazole, furane and thiophene compounds as microbicides |
| EP2447261A1 (en) * | 2010-10-29 | 2012-05-02 | Basf Se | Pyrrole, furane and thiophene derivatives and their use as fungicides |
| AU2012300275A1 (en) * | 2011-08-30 | 2014-03-06 | Innocrin Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4367090A (en) * | 1981-07-17 | 1983-01-04 | Rhone-Poulenc Agrochimie | Herbicidal N-(5,5-dimethyloxazolideneyl-2,4-dione) 5-(substituted phenoxy-2-substituted benzamides |
| JPS58148882A (ja) * | 1982-02-26 | 1983-09-05 | Tanabe Seiyaku Co Ltd | フリルオキサゾリル酢酸誘導体及びその製法 |
| JPS58150576A (ja) * | 1982-03-03 | 1983-09-07 | Sumitomo Chem Co Ltd | 新規な１，２，４−オキサジアゾ−ル誘導体 |
| JPH01249760A (ja) * | 1988-03-29 | 1989-10-05 | Yamaha Corp | ホトクロミック化合物 |
| SU1657505A1 (ru) * | 1989-07-17 | 1991-06-23 | Казанский научно-исследовательский технологический и проектный институт химико-фотографической промышленности Производственного объединения "Тасма" | Производные 1-(морфолинокарбонил)-или 1-(морфолинокарбонилокси)-пиридиний хлорида в качестве дубителей дл желатинсодержащих слоев галогенсеребр ных фотографических материалов |
| US5086064A (en) * | 1990-03-27 | 1992-02-04 | Warner-Lambert Company | 3,5-di-tertiary-butyl-4-hydroxyphenyl thiazolyl, oxazolyl, and imidazolyl methanones and related compounds as antiinflammatory agents |
| US5068237A (en) * | 1990-05-21 | 1991-11-26 | Warner-Lambert Company | Substituted furans and derivatives thereof acting at muscarinic receptors |
| EP0619814A1 (en) * | 1991-12-31 | 1994-10-19 | Fujisawa Pharmaceutical Co., Ltd. | Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity |
-
1993
- 1993-07-06 SE SE19939302332A patent/SE9302332D0/xx unknown
-
1994
- 1994-06-23 IS IS4182A patent/IS4182A/is unknown
- 1994-06-24 ZA ZA944569A patent/ZA944569B/xx unknown
- 1994-06-29 IL IL11015794A patent/IL110157A/xx not_active IP Right Cessation
- 1994-07-05 CN CN94192713A patent/CN1126994A/zh active Pending
- 1994-07-05 BR BR9406923A patent/BR9406923A/pt not_active Application Discontinuation
- 1994-07-05 PL PL94312417A patent/PL176471B1/pl unknown
- 1994-07-05 AU AU71977/94A patent/AU691506B2/en not_active Ceased
- 1994-07-05 RU RU96103659A patent/RU2124011C1/ru active
- 1994-07-05 NZ NZ268689A patent/NZ268689A/en unknown
- 1994-07-05 FI FI960076A patent/FI960076A0/fi unknown
- 1994-07-05 WO PCT/SE1994/000663 patent/WO1995001979A1/en not_active Ceased
- 1994-07-05 US US08/379,506 patent/US5731335A/en not_active Expired - Fee Related
- 1994-07-05 SG SG1996005493A patent/SG64891A1/en unknown
- 1994-07-05 CZ CZ9653A patent/CZ5396A3/cs unknown
- 1994-07-05 SK SK1598-95A patent/SK159895A3/sk unknown
- 1994-07-05 EP EP94921147A patent/EP0707584A1/en not_active Withdrawn
- 1994-07-05 JP JP7503998A patent/JPH08512312A/ja active Pending
- 1994-07-05 HU HU9503744A patent/HUT75097A/hu unknown
- 1994-07-05 CA CA002164856A patent/CA2164856A1/en not_active Abandoned
- 1994-07-05 MX MX9405110A patent/MX9405110A/es not_active IP Right Cessation
- 1994-07-06 EG EG40594A patent/EG20569A/xx active
- 1994-11-23 EE EE9400387A patent/EE03193B1/xx unknown
-
1995
- 1995-06-02 US US08/459,847 patent/US5607956A/en not_active Expired - Fee Related
-
1996
- 1996-01-04 NO NO960028A patent/NO305955B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA944569B (en) | 1995-02-15 |
| RU2124011C1 (ru) | 1998-12-27 |
| IS4182A (is) | 1995-01-07 |
| US5731335A (en) | 1998-03-24 |
| EE03193B1 (et) | 1999-06-15 |
| EP0707584A1 (en) | 1996-04-24 |
| NO960028L (no) | 1996-02-27 |
| JPH08512312A (ja) | 1996-12-24 |
| CN1126994A (zh) | 1996-07-17 |
| MX9405110A (es) | 1995-01-31 |
| EG20569A (en) | 1999-08-30 |
| FI960076A7 (fi) | 1996-01-08 |
| WO1995001979A1 (en) | 1995-01-19 |
| AU7197794A (en) | 1995-02-06 |
| FI960076L (fi) | 1996-01-08 |
| NZ268689A (en) | 1997-11-24 |
| SG64891A1 (en) | 1999-05-25 |
| IL110157A0 (en) | 1994-10-07 |
| NO305955B1 (no) | 1999-08-23 |
| NO960028D0 (no) | 1996-01-04 |
| SK159895A3 (en) | 1996-09-04 |
| FI960076A0 (fi) | 1996-01-08 |
| CZ5396A3 (en) | 1996-06-12 |
| CA2164856A1 (en) | 1995-01-19 |
| HUT75097A (en) | 1997-04-28 |
| SE9302332D0 (sv) | 1993-07-06 |
| HU9503744D0 (en) | 1996-02-28 |
| US5607956A (en) | 1997-03-04 |
| PL312417A1 (en) | 1996-04-15 |
| AU691506B2 (en) | 1998-05-21 |
| IL110157A (en) | 2000-01-31 |
| PL176471B1 (pl) | 1999-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9302737A (pt) | Derivados de tiazolivinilfenila,processo para a preparacao de um composto,medicamento,uso e processos para tratar ou prevenir asma bronquica | |
| BR9609780A (pt) | Composto uso de um composto processo para o tratamento de condições composição farmacêutica processos para preparar uma composição farmacêutica e para preparar um composto | |
| BR9406128A (pt) | Uso de um composto processo para o tratamento e/ou prevençao de distúrbios psicóticos composto composiçao farmacêutica processos para a preparaçao de um composto e de uma composiçao farmacêutica | |
| BR9407869A (pt) | Combinaçao composiçao farmacêutica e processo para o tratamento de osteoporose | |
| BR9408148A (pt) | Processo para tratamento de arritmia composto e formulação farmacêutica | |
| BR9611986A (pt) | Compostos processo para a preparação dos mesmos composição farmcéutica e utilização dos compostos | |
| BR9609467A (pt) | Composto uso de um composto composição farmacéutica e processos para preparação de um composto e tratamento de distúrbios de agregação planquetária | |
| BR9406566A (pt) | Composição farmacêutica uso de progesterona e/ou 17 - - estradiol e processo para a fabricação de uma preparação farmacêutica | |
| BR9602705A (pt) | Composto composição farmacéutica processo para a preparação de um composto e uso | |
| BR1100850A (pt) | Composto, processo para a preparação de um composto, e, composição farmacêutica | |
| BR9610988A (pt) | Composto uso do mesmo fomulação farmacêutica e processo para produção do composto | |
| BR9406923A (pt) | Compostos derivados de (1-heteroazolil-1-heterociclil)alcano processo para preparar os mesmos formulaçao farmaceutica uso de compostos e processo para o tratamento de disturbios neuropsiquiatricos cronicos e agudos | |
| BR9612204A (pt) | Composto uso do composto composição farmacêutica e processo para preparação do composto e para o tratamento de dor | |
| PT93094A (pt) | Processo para a preparacao de 1,3-oxatiolanos substituidos e de composicoes farmaceuticas que os contem | |
| BR1100323A (pt) | Composto, uso de um composto, composição farmacêutica e processo para preparar um composto | |
| PT98369A (pt) | Processo para a preparacao de azois substituidos e de composicoes farmaceuticas que os contem | |
| BR9505107A (pt) | Composto composiçao farmacêutica processo para a preparaçao de um composto e seu uso | |
| BR9611377A (pt) | Inibidor de trombina de ligação não lenta processo para preparar o mesmo composição farmacêutica e uso do inibidor de trombina | |
| BR9506473A (pt) | Composto processo para a preparação de compostos utilização de um composto composição farmacêutica e processo para o tratamento de infecções anti-fúngicas | |
| BR9502471A (pt) | Composto de guanidina processo para preparar um composto de guanidina composição farmaceutica uso de um composto de guanidina método para o tratamento profilático ou terapêutico de doenças e processo para preparar uma composição farmacêutica | |
| PT89497A (pt) | Processo para a preparacao de compostos piperidinilicos 1,4-dissubstituidos e de composicoes farmaceuticas que os contem | |
| BR9106117A (pt) | Antraquinona substituida,composicao farmaceutica para inibir quinase c de proteina,processo para tal inibicao e uso de um composto | |
| BR9005793A (pt) | Composicao de fluoreto estanoso aquoso estabilizada e processo para preparacao da mesma | |
| BR9600339A (pt) | Compostos composições farmacêuticas processo para a preparação de um composto e uso dos mesmos | |
| BR9607264A (pt) | Composto derivado do isotiuréia composição farmacêutica uso de tal composto e processo para a preparação dos mesmos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EG | Technical examination (opinion): publication of technical examination (opinion) | ||
| FC | Decision: refusal |